News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Omeros Corporation (OMER) Reports First Quarter 2013 Financial Results


5/10/2013 7:16:19 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 10, 2013 — /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the first quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at The Herald

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES